Search results: Sage Journals

Restricted accessReview articleFirst published May, 2026

Toripalimab and Penpulimab: Targeting PD-1 in Recurrent or Metastatic Nasopharyngeal Carcinoma

Josie J. Hockett, Molly E. Keller, David J. Reeves

Annals of Pharmacotherapy

Open accessResearch articleFirst published 2021

Lenvatinib,toripalimab,plus hepatic arterial infusion chemotherapy versus lenvatinib alone for advanced hepatocellular carcinoma

Min-Ke He, Run-Bin Liang, Yang Zhao [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2021

Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular Carcinoma

Yu-Jie Xu, Zhi-Cheng Lai, Min-Ke He [...]

Technology in Cancer Research & Treatment

Restricted accessCase reportFirst published December, 2021

Efficacy of chemotherapy combined with toripalimab in PD-L1–positive and high tumor mutation burden pancreatic acinar cell carcinoma: case report

Huanji Xu, Xin Wang, Sheng Zhou [...]

Tumori Journal

Open accessCase reportFirst published October, 2021

Toripalimab in an advanced non-small cell lung cancer patient with poor general condition after multiline treatment: a case report

Yuling He, Tongtong An

Journal of International Medical Research

Open accessCase reportFirst published October, 2022

Chemotherapy combined with immunotherapy in primary female urethral squamous cell carcinoma: a case report

Hongsong Bai, Huifu Han, Fan Wang [...]

Journal of International Medical Research

Restricted accessResearch articleFirst published April, 2024

Efficacy and Safety of Immune Checkpoint Inhibitors Combined With Chemotherapy as First-line Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Network Meta-analysis of Randomized Controlled Trials

Hong Sun, Fengjiao Bu, Ling Li [...]

Annals of Pharmacotherapy

Open accessResearch articleFirst published 2022

Sorafenib,Lenvatinib,or Lenvatinib Combining PD-1 Inhibitors Plus TACE in Unresectable Hepatocellular Carcinoma: A Retrospective Analysis

Shu Zhao, Minhang Zhou, Peng Wang [...]

Technology in Cancer Research & Treatment

Open accessCase reportFirst published 2025

First case report of immune checkpoint inhibitor therapy to treat secretory carcinoma

Xiangyang Yu, Xiaoxing Ye, Mengqi Zhang [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2025

Unveiling the best immune checkpoint inhibitor-based therapy for metastatic renal cell carcinoma in the first-line setting: an updated systematic review and Bayesian network analysis

Junpeng Wang, Xin Li, Mengjun Li [...]

Therapeutic Advances in Medical Oncology

Restricted accessReview articleFirst published May, 2026

Toripalimab and Penpulimab: Targeting PD-1 in Recurrent or Metastatic Nasopharyngeal Carcinoma

Josie J. Hockett, Molly E. Keller, David J. Reeves

Annals of Pharmacotherapy

Open accessResearch articleFirst published 2021

Lenvatinib,toripalimab,plus hepatic arterial infusion chemotherapy versus lenvatinib alone for advanced hepatocellular carcinoma

Min-Ke He, Run-Bin Liang, Yang Zhao [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2021

Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular Carcinoma

Yu-Jie Xu, Zhi-Cheng Lai, Min-Ke He [...]

Technology in Cancer Research & Treatment

Restricted accessCase reportFirst published December, 2021

Efficacy of chemotherapy combined with toripalimab in PD-L1–positive and high tumor mutation burden pancreatic acinar cell carcinoma: case report

Huanji Xu, Xin Wang, Sheng Zhou [...]

Tumori Journal

Open accessCase reportFirst published October, 2021

Toripalimab in an advanced non-small cell lung cancer patient with poor general condition after multiline treatment: a case report

Yuling He, Tongtong An

Journal of International Medical Research

Open accessCase reportFirst published October, 2022

Chemotherapy combined with immunotherapy in primary female urethral squamous cell carcinoma: a case report

Hongsong Bai, Huifu Han, Fan Wang [...]

Journal of International Medical Research

Restricted accessResearch articleFirst published April, 2024

Efficacy and Safety of Immune Checkpoint Inhibitors Combined With Chemotherapy as First-line Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Network Meta-analysis of Randomized Controlled Trials

Hong Sun, Fengjiao Bu, Ling Li [...]

Annals of Pharmacotherapy

Open accessResearch articleFirst published 2022

Sorafenib,Lenvatinib,or Lenvatinib Combining PD-1 Inhibitors Plus TACE in Unresectable Hepatocellular Carcinoma: A Retrospective Analysis

Shu Zhao, Minhang Zhou, Peng Wang [...]

Technology in Cancer Research & Treatment

Open accessCase reportFirst published 2025

First case report of immune checkpoint inhibitor therapy to treat secretory carcinoma

Xiangyang Yu, Xiaoxing Ye, Mengqi Zhang [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2025

Unveiling the best immune checkpoint inhibitor-based therapy for metastatic renal cell carcinoma in the first-line setting: an updated systematic review and Bayesian network analysis

Junpeng Wang, Xin Li, Mengjun Li [...]

Therapeutic Advances in Medical Oncology